Global Chronic Idiopathic Constipation Drug Market Forecast 2017-2025

Publisher Name :
Date: 24-Sep-2017
No. of pages: 122

Key Findings

Global Chronic Idiopathic Constipation drug market is estimated to grow at a CAGR of 8.37% during the forecast period of 2017-2025. The important drivers propelling the market growth are the modern dietary habits, rising elderly population and the improved and efficient drugs in the pipeline. Linaclotide is the major type of drug popular in this market.

Market Insight

The CIC drug market is segmented based on drug types and also on the basis of prescription types. The drug types include Linaclotide, Lubiprostone, and others. The prescription type segment is further divided into over the counter drugs and prescribed drugs. An increasing demand for CIC drug from the Asia-Pacific market, coupled with the high unmet needs globally is providing the market with plenty of growth opportunities.

Regional Insights

Geographically, the global CIC drug market is segmented four major regions which include North America, Asia Pacific, Europe and Rest of World. The North America is touted to account for the largest share during the forecast period on account of its developed healthcare systems and medical devices industry. Approximately 28% of the population residing there suffer from CIC. The growing government initiatives to treat and improve the healthcare segment of the society by providing latest technological and advance medical treatments are also aiding the market growth.

Competitive Insights

Advanced product launch is the key strategy adopted by the various market players of global CIC drug market. The other strategies include acquisition and mergers. For example, Roche holding Inc acquired Ariosa Diagnostics Inc, which provides non-invasive prenatal testing (NIPT) service using cell-free DNA (cf-DNA) technology. Also, Allergan announced a collaboration with the company AstraZeneca in order to develop and commercialize ATM-AVI (aztreonam and avibactam) for antibiotic-resistant gram-negative infections. The other major players in the market include Synergy Pharmaceuticals, GlaxoSmithKline, Sucampo Pharmaceuticals Inc, Pfizer, Ironwood Pharmaceuticals Inc, etc.

Global Chronic Idiopathic Constipation Drug Market Forecast 2017-2025

Table of Contents

1. Research Scope
1.1. Study Goals
1.2. Scope of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study and Forecasting Years
2. Research Methodology
2.1. Sources of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
4. Market Overview
4.1. Market Definition
4.2. Key Market Insights
4.3. Attractive Investment Scenario
4.4. Positioning of Key Cic Drugs Manufacturers In The Market
4.5. Market Drivers
4.5.1. Modern Dietary Habits Taking Toll On The Health
4.5.2. Cancer Or Other Systematic Disease Can Lead To Cic
4.5.3. Increasing Elderly Population
4.5.4. Improved and Efficient Drugs In Pipeline
4.5.5. Increasing Constipation Problems Due To Side Effects of Prescribed Medicines
4.6. Restraints
4.6.1. Surgical Treatments
4.6.2. Unawareness and Ignorance Among People
4.7. Opportunities
4.7.1. Increasing Demand For Cic Drug From Apac Market
4.7.2. High Unmet Needs
4.8. Challenges
4.8.1. Side Effects of Cic Drugs
5. Global Cic Drugs Market, By Drug Type 2017-2025 ($ Million)
5.1. Overview
5.1.1. Lubiprostone
5.1.2. Linaclotide
5.1.3. Others
5.2. Pipeline Drug Analysis: Phase 3: Plecanatide (Year of Launch 2022, $ Million)
5.3. Pipeline Drug Analysis: Phase 3: Elobixibat (Year of Launch 2022, $ Million)
6. Global Cic Drugs Market By Prescription Type 2017-2025 ($ Million)
6.1. Prescribed Drugs
6.2. Over The Counter Drugs
7. Key Analytics
7.1. Porters Five Force Analysis
7.1.1. Intensity of Competitive Rivalry
7.1.2. Bargaining Power of Suppliers
7.1.3. Bargaining Power of Buyers
7.1.4. Threat of Substitute Products
7.1.5. Threat of New Entrants
7.2. Vendor Landscape
7.3. Opportunity Matrix
8. Global Cic Drugs Market By Geography 2017-2025 ($ Million)
8.1. North America
8.1.1. Us
8.1.2. Canada
8.2. Europe
8.2.1. Uk
8.2.2. Germany
8.2.3. Rest of Europe
8.3. Asia Pacific
8.3.1. China
8.3.2. Japan
8.3.3. Rest of Asia Pacific
8.4. Rest of The World
8.4.1. Middle East and Africa
8.4.2. Latin America
9. Company Profiles
9.1. Allergens
9.1.1. Overview
9.1.2. Product Portfolio
9.1.3. Strategic Moves
9.1.4. Scot Analysis
9.2. Chugai Pharmaceutical
9.2.1. Overview
9.2.2. Product Portfolio
9.2.3. Strategic Moves
9.2.4. Scot Analysis
9.3. Ferring International Center S.A.
9.3.1. Overview
9.3.2. Product Portfolio
9.3.3. Scot Analysis
9.4. Synergy Pharmaceuticals
9.4.1. Overview
9.4.2. Product Portfolio
9.4.3. Scot Analysis
9.5. Pfizer
9.5.1. Overview
9.5.2. Pfizer Product Portfolio
9.5.3. Scot Analysis
9.6. Glaxosmithkline
9.6.1. Overview
9.6.2. Product Portfolio
9.6.3. Scot Analysis
9.7. Roche Holding Ag
9.7.1. Overview
9.7.2. Product Portfolio
9.7.3. Strategic Moves
9.7.4. Scot Analysis
9.8. Sanofi
9.8.1. Overview
9.8.2. Product Portfolio
9.8.3. Scot Analysis
9.9. Bayer Ag
9.9.1. Overview
9.9.2. Product Portfolio
9.9.3. Scot Analysis
9.10. Merck Sharp & Dohme
9.10.1. Overview
9.10.2. Product Portfolio
9.10.3. Scot Analysis
9.11. Eli Lilly and Company
9.11.1. Overview
9.11.2. Product Portfolio
9.11.3. Scot Analysis
9.12. Salix Pharmaceuticals Ltd
9.12.1. Overview
9.12.2. Product Portfolio
9.12.3. Scot Analysis
9.13. Sucampo Pharmaceuticals Inc
9.13.1. Overview
9.13.2. Product Portfolio
9.13.3. Scot Analysis
9.14. Ironwood Pharmaceuticals Inc
9.14.1. Overview
9.14.2. Product Portfolio
9.14.3. Scot Analysis
9.15. Valeant Pharmaceuticals International
9.15.1. Overview
9.16. Daiichi Sankyo Co Ltd
9.16.1. Overview
9.16.2. Product Portfolio
9.16.3. Scot Analysis
9.17. Cosmo Pharmaceuticals Sa
9.17.1. Overview
9.17.2. Product Portfolio
9.17.3. Scot Analysis
9.18. Progenics Pharmaceuticals Inc
9.18.1. Overview
9.18.2. Product Portfolio
9.18.3. Scot Analysis
9.19. Theravance Biopharma Inc
9.19.1. Overview
9.19.2. Product Portfolio
9.19.3. Scot Analysis
List of Tables
Table 1 Global Cic Drug Market By Geography 2017-2025 ($ Million)
Table 2 Prominent Drugs and Their Respective Companies In Therapeutics For Chronic Constipation
Table 3 Constipation In Parkinson's Disease
Table 4 Common Medicines Causing Constipation
Table 5 Global Cic Drugs Market By Drug Type 2014-2022($ Million)
Table 6 Product Profile (Lubiprostone)
Table 7 Lubiprostone Drug Market By Geography 2017-2025 ($ Million)
Table 8 Product Profile (Linaclotide)
Table 9 Linaclotide Drug Market By Geography 2017-2025 ($ Million)
Table 10 Product Profile (Bisacodyl)
Table 11 Others Drug Market By Geography 2017-2025 ($ Million)
Table 12 Pipeline Product Profile (Plecanatide)
Table 13 Pipeline Product Profile (Elobixibat)
Table 14 Global Cic Drugs Market By Prescription Type 2017-2025 ($ Million)
Table 15 Global Prescribed Cic Drugs Market, By Geography 2017-2025 ($ Million)
Table 16 Linzess Precautions and Side Effects
Table 17 Global Over The Counter Cic Drug Market By Geography 2017-2025 ($ Million)
Table 18 North America Cic Drugs Market By Country 2017-2025 ($ Million)
Table 19 U.S. Cic Drugs Market By Prescription Type 2017-2025 ($ Million)
Table 20 U.S. Cic Drugs Market By Major Drugs 2017-2025 ($ Million)
Table 21 Canada Cic Drugs Market By Prescription Type 2017-2025 ($ Million)
Table 22 Canada Cic Drugs Market By Major Drugs 2017-2025 ($ Million)
Table 23 Europe Cic Drugs Market By Country 2017-2025 ($ Million)
Table 24 Uk Cic Drugs Market By Prescription Type 2017-2025 ($ Million)
Table 25 Uk Cic Drugs Market By Major Drugs 2017-2025 ($ Million)
Table 26 Germany Cic Drugs Market By Prescription Type 2017-2025 ($ Million)
Table 27 Germany Cic Drugs Market By Major Drugs 2017-2025 ($ Million)
Table 28 Asia Pacific Cic Drugs Market By Country 2017-2025 ($ Million)
Table 29 China Cic Drug Market By Prescription Type 2017-2025 ($ Million)
Table 30 China Cic Drug Market By Major Drugs 2017-2025 ($ Million)
Table 31 Japan Cic Drug Market By Prescription Type 2017-2025 ($ Million)
Table 32 Japan Cic Drug Market By Major Drugs 2017-2025 ($ Million)
Table 33 Rest of World Cic Drugs Market, By Region, 2017-2025 ($ Million)
Table 34 Mena Cic Drug Market By Prescription Type 2017-2025 ($ Million)
Table 35 Mena Cic Drug Market By Major Drugs 2017-2025 ($ Million)
Table 36 Latin America Cic Drug Market By Prescription Type 2017-2025 ($ Million)
Table 37 Latin America Cic Drug Market By Major Drugs 2017-2025 ($ Million)

List of Figures
Figure 1 Global Chronic Idiopathic Constipation (Cic) Drug Market 2017-2025 ($ Million)
Figure 2 Global Cic Drug Market By Drug Type 2017-2025 ($ Million)
Figure 3 Global Cic Drug Market By Prescription Type In 2016 ($ Million)
Figure 4 Causes of Constipation
Figure 5 Proportion of Population Aged 60 Or Above In 2014
Figure 6 Major Causes of Constipation In Elderly People
Figure 7 Effective Drugs To Create Huge Market Benefits
Figure 8 Surgical Options Available For Constipation
Figure 9 Need of Surgery Process
Figure 10 Apac Cic Market 2017-2025 ($ Million)
Figure 11 Common Constipation Drugs and Side Effects Caused Due To Them
Figure 12 Global Lubiprostone Drug Market 2017-2025 ($ Million)
Figure 13 Global Linaclotide Drug Market 2017-2025 ($ Million)
Figure 14 Global Other Drugs Market 2017-2025 ($ Million)
Figure 15 Global Prescribed Cic Drugs Market 2017-2025 ($ Million)
Figure 16 Global Over The Counter Cic Drug Market 2017-2025 ($ Million)
Figure 17 North America Cic Drugs Market 2017-2025 ($ Million)
Figure 18 Us Cic Market, 2017-2025 ($ Million)
Figure 19 Canada Cic Market 2017-2025 ($ Million)
Figure 20 Europe Cic Drugs Market 2017-2025 ($ Million)
Figure 21 Uk Cic Drug Market 2017-2025 ($ Million)
Figure 22 Germany Cic Drug Market, 2017-2025 $ Million)
Figure 23 Rest of Europe Cic Drug Market 2017-2025 ($ Million)
Figure 24 Asia Pacific Cic Drug Market 2017-2025 ($ Million)
Figure 25 China Cic Drug Market 2017-2027 ($ Million)
Figure 26 Comparison of Pharmaceutical Sales Across The Globe
Figure 27 Japan Cic Drug Market 2017-2025 ($ Million)
Figure 28 Rest of Apac Cic Drug Market 2017-2025 ($ Million)
Figure 29 Middle East & Africa Cic Drugs Market 2017-2025 ($ Million)
Figure 30 Latin America Cic Drug Market 2017-2025 ($ Million)
  • Global Anti-Peptic Ulcer Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 11-Jun-2018        Price: US 3480 Onwards        Pages: 132
    Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. Scope of the Report: This report focuses on the Anti-Peptic Ulcer Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. China's anti-......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Anti-Peptic Ulcer Drugs Market 2018, Forecast to 2023
    Published: 11-Jun-2018        Price: US 4880 Onwards        Pages: 132
    Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. Scope of the Report: This report focuses on the Anti-Peptic Ulcer Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. China's anti-......
  • Global Proglumide Market Outlook 2018-2023
    Published: 04-Jun-2018        Price: US 2500 Onwards        Pages: 116
    The report segments the market and forecasts its size, by volume and value, on the basis of product, by application, and by geography (North America, Europe, Asia-Pacific, MEA and South America). The report covers forecast and analysis for the proglumide market on a global and regional level. The study provides historic data of 2013-2017 along with a forecast from 2018 to 2023 based on both output/volume and revenue. The study then describes the drivers and restraints for the proglu......
  • Global Anti Peptic Ulcer Drugs Market Size, Status and Forecast 2025
    Published: 01-Jun-2018        Price: US 3300 Onwards        Pages: 104
    This report studies the global Anti Peptic Ulcer Drugs market, analyzes and researches the Anti Peptic Ulcer Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Eisai - Daewoong Pharmaceutical - Takeda Pharmaceutical - HeliCure - AstraZeneca - Ore Pharmaceuticals - Sihuan Pharmaceutical - GlaxoSmithKline - Pfizer - A......
  • China Gastrointestinal OTC Drugs Market Research Report 2018
    Published: 30-May-2018        Price: US 3400 Onwards        Pages: 107
    The global Gastrointestinal OTC Drugs market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Gastrointestinal OTC Drugs development status and future trend in China, focuses on top players in China, also......
  • Mexico Gastrointestinal OTC Drugs Market Research Report 2018
    Published: 30-May-2018        Price: US 3400 Onwards        Pages: 106
    The global Gastrointestinal OTC Drugs market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Mexico plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Gastrointestinal OTC Drugs development status and future trend in Mexico, focuses on top players in Mexico, a......
  • 2018-2023 Global Top Countries Gastrointestinal Drug Market Report
    Published: 29-May-2018        Price: US 4960 Onwards        Pages: 117
    In 2017, the global Gastrointestinal Drug market size was xx million USD, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. This report studies Gastrointestinal Drug in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle East and Africa, focuses on the top Players in each country, covering - AstraZenec - Sanofi - Baye......
  • 2018-2023 India Gastrointestinal Drug Market Report (Status and Outlook)
    Published: 29-May-2018        Price: US 3360 Onwards        Pages: 87
    In 2017, the Gastrointestinal Drug market size was xx million USD in India, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In India market, the top players include - AstraZenec - Sanofi - Bayer - Pfizer - GlaxoSmithKline - Teva - Zeria(Tillotts) - Perrigo - Boehringer Ingelheim - Purdue Pharma - C.B. Fleet - Abbott - Jiangzhong - Xian-Janssen ......
  • 2018-2023 Malaysia Gastrointestinal Drug Market Report (Status and Outlook)
    Published: 29-May-2018        Price: US 3360 Onwards        Pages: 87
    In 2017, the Gastrointestinal Drug market size was xx million USD in Malaysia, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In Malaysia market, the top players include - AstraZenec - Sanofi - Bayer - Pfizer - GlaxoSmithKline - Teva - Zeria(Tillotts) - Perrigo - Boehringer Ingelheim - Purdue Pharma - C.B. Fleet - Abbott - Jiangzhong - Xian-Janssen......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs